Acute pancreatitis-induced by platinum compounds in patients with cancer: a review of the literature

Abdulqadir J. Nashwan, Mohamed A. Yassin, Sindhumole L. Nair


The purpose of this review of the literature was to describe the relationship between use of platinum-based antineoplastics and development of acute pancreatitis in patients with cancer. A literature search was conducted using PubMed, Science Direct and Google scholar databases for articles published from 1985 to 2014. The headings and/or text words (platinum compounds), (acute pancreatitis-induced by platinum compounds), and (cisplatin, carboplatin, and oxaliplatin) were entered, and the search was limited to articles describing case reports in adults with cancer. A total of 12 cases were reported between 1985 and 2012; including three platinum compounds; cisplatin, carboplatin, and oxaliplatin. In conclusion, it is highly recommended to include baseline assessment for acute pancreatitis risk factors and to consider acute pancreatitis in the differential diagnosis of abdominal pain in patients who have received platinum-based chemotherapy.


Acute pancreatitis, Platinum compounds, Cisplatin, Carboplatin, Oxaliplatin

Full Text:



Nitsche CJ, Jamieson N, Lerch MM, Mayerle JV. Drug induced pancreatitis. Best Pract Res Clin Gastroenterol. 2010;24(2):143-55.

Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg. 1990;211(4):447-58.

Hart PA, Bechtold ML, Marshall JB, Choudhary A, Puli SR, Roy PK. Prophylactic antibiotics in necrotizing pancreatitis: a meta-analysis. South Med J. 2008;101(11):1126-31.

Underwood TW, Frye CB. Drug-induced pancreatitis. Clin Pharm. 1993;12(6):440-8.

Frick TW, Speiser DE, Bimmler D, Largiadèr F. Drug-induced acute pancreatitis: further criticism. Dig Dis. 1993;11(2):113-32.

Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev. 2007;33(1):9-23.

Jamieson ER, Lippard SJ. Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev. 1999;99(9):2467-98.

Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol. 2005;39(8):709-16.

Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007;5(6):648-61.

Bunin N, Meyer WH, Christensen M, Pratt CB. Pancreatitis following cisplatin: a case report. Cancer Treat Rep. 1985;69(2):236-7.

Tarin F, Camps C, Berrocal A, Vicent JM. Acute pancreatitis caused by cisplatin and vindesine. Rev Esp Enferm Dig. 1994;85(3):224-5.

Bilir C, Engin H, Ustun H, Ustundag Y. Gemcitabine-cisplatin induced acute pancreatitis: a case report. Health MED. 2012;6(5):1863-4.

Socinski MA, Garnick MB. Acute pancreatitis associated with chemotherapy for germ cell tumors in two patients. Ann Intern Med. 1988;108(4):567-8.

Butt W, Saadati H, Saif MW. Oxaliplatin-induced pancreatitis: a case series. Anticancer Res. 2010;30(12):5113-5.

Natarajan G, Malathi R, Holler E. Increased DNA-binding activity of cis-1,1-cyclobutanedicarboxylatodiammineplatinum(II) (carboplatin) in the presence of nucleophiles and human breast cancer MCF-7 cell cytoplasmic extracts: activation theory revisited. Biochem Pharmacol. 1999;58(10):1625-9.

Smith IE, Harland SJ, Robinson BA, Evans BD, Goodhart LC, Calvert AH, et al. Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer. Cancer Treat Rep. 1985;69(1):43-6.

Singh V, Devata S, Cheng YC. Carboplatin and docetaxel-induced acute pancreatitis: brief report. Int J Clin Oncol. 2010;15(6):642-4.